MPEP § 2431 — Sample “Sequence Listing” under WIPO ST.25
Ninth Edition, Revision 01.2024 · last revised R-07.2022
[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP §§ 2412-2419 for guidance on WIPO ST.26 requirements for applications filed on or after July 1, 2022.]
A sample “Sequence Listing” is included below.
Cited authority
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 2412 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format
- 2419 Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”